SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The Federal Reserve Board published its annual assessment of American household economic conditions for 2025. The report provides data on household finances, employment, and econom…
The Federal Reserve Board has terminated enforcement actions with F&M Holding Company, Inc. and Thread Bancorp, Inc. The action indicates these institutions have resolved complianc…
The FDA has finalized its post-market assessment program for food chemicals and initiated a reassessment of BHT and ADA safety. This action is part of the FDA's expanded food safet…
The FDA announced it is seeking stakeholder input on drug repurposing efforts to address unmet medical needs across various diseases and conditions. The initiative aims to leverage…
The Federal Reserve Board has approved related applications submitted by Columbia Bank MHC and Columbia Financial, Inc. The approval allows these entities to proceed with their reg…
The FDA granted approval for Bizengri (zenocutuzumab-zbco), marking the seventh approval under the National Priority Voucher Pilot Program. The drug treats NRG1 fusion-positive cho…
The FDA released final guidance recommending methodologies for studying drug and biologic safety during pregnancy in the postapproval setting. The guidance aims to improve collecti…
The FDA announced the launch of Elsa 4.0, an upgraded internal AI tool now available to all agency staff including scientific reviewers and investigators. The initiative is part of…
The FDA announced a pilot program for one-day inspectional assessments to make its inspectional resources more targeted and efficient. The initiative is part of the agency's broade…
The FDA approved the marketing of four Glas ENDS products through the premarket tobacco product application pathway. This authorization expands market access for the company's elec…
The FDA issued a 'safe to proceed' letter to Revolution Medicines for an expanded access treatment protocol of daraxonrasib, an experimental pancreatic cancer drug. The authorizati…
Federal banking agencies have released loan-to-deposit ratios for host states, providing updated metrics on lending activity relative to deposits across different jurisdictions. Th…
The FDA approved an expanded use for Auvelity (dextromethorphan/bupropion) to treat agitation associated with Alzheimer's dementia in adults. This marks the first non-antipsychotic…
The FDA is proposing to remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list, determining there is no clinical need for outsourcing facilities to compound thes…
The Federal Reserve's Federal Open Market Committee issued a statement regarding monetary policy decisions. The statement addresses current economic conditions and the Fed's policy…
The FDA released results from its largest and most rigorous examination of chemical contaminants in infant formula available in the U.S. market. The comprehensive testing represent…
The FDA announced two major steps to advance real-time clinical trials (RTCT) implementation. The initiative aims to modernize clinical trial processes.
The Federal Reserve Board has approved an application submitted by OceanFirst Financial Corp. The approval permits the company to proceed with its requested regulatory action.
The Federal Reserve Board has approved an application submitted by Banco de Credito del Peru. The approval allows the Peruvian financial institution to proceed with its requested r…
President Trump issued an Executive Order on April 18 directing HHS to accelerate access to treatments for serious mental illness, including treatment-resistant conditions. The FDA…